
BUTYLATED HYDROXYTOLUENE USP/EU
Excipient designed for solid and semi-solid dosage forms. Antioxidant and reducing agent developed for injectable formulations.Benefits:DMF Filed - CDE # F20200000189Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)




